Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 4,450.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 16,374
  • Market Cap: £232.27m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
13.16% above the market average13.16% above the market average13.16% above the market average13.16% above the market average13.16% above the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
1yr Revenue Growth
4.4% below the market average4.4% below the market average4.4% below the market average4.4% below the market average4.4% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
8.09% below the market average8.09% below the market average8.09% below the market average8.09% below the market average8.09% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
1yr DPS Growth
58.66% above the market average58.66% above the market average58.66% above the market average58.66% above the market average58.66% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
55.56% above the market average55.56% above the market average55.56% above the market average55.56% above the market average55.56% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average
Price Book Ratio
96.82% below the market average96.82% below the market average96.82% below the market average96.82% below the market average96.82% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
62.37% below the market average62.37% below the market average62.37% below the market average62.37% below the market average62.37% below the market average
22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average
Price Chg 3m
42.84% above the market average42.84% above the market average42.84% above the market average42.84% above the market average42.84% above the market average
43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
78.86% below the market average78.86% below the market average78.86% below the market average78.86% below the market average78.86% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Momentum 20
99.47% below the market average99.47% below the market average99.47% below the market average99.47% below the market average99.47% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
74.56% above the market average74.56% above the market average74.56% above the market average74.56% above the market average74.56% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
ROCE
81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
92.39% above the market average92.39% above the market average92.39% above the market average92.39% above the market average92.39% above the market average
92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average
Forecast EPS
82.70% above the market average82.70% above the market average82.70% above the market average82.70% above the market average82.70% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.28% below the market average35.28% below the market average35.28% below the market average35.28% below the market average35.28% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Operating Profit Loss
27.81% above the market average27.81% above the market average27.81% above the market average27.81% above the market average27.81% above the market average
70.37% above the sector average70.37% above the sector average70.37% above the sector average70.37% above the sector average70.37% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
27.22% below the market average27.22% below the market average27.22% below the market average27.22% below the market average27.22% below the market average
15.38% above the sector average15.38% above the sector average15.38% above the sector average15.38% above the sector average15.38% above the sector average
Cash
15.66% below the market average15.66% below the market average15.66% below the market average15.66% below the market average15.66% below the market average
3.70% above the sector average3.70% above the sector average3.70% above the sector average3.70% above the sector average3.70% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
77.22% above the market average77.22% above the market average77.22% above the market average77.22% above the market average77.22% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Buys 1y
56.16% below the market average56.16% below the market average56.16% below the market average56.16% below the market average56.16% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,450.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 16,374
Shares Issued 5.22m
Market Cap £232.27m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
77.14% above the market average77.14% above the market average77.14% above the market average77.14% above the market average77.14% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average
Income
29.89% below the market average29.89% below the market average29.89% below the market average29.89% below the market average29.89% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
36.92% below the market average36.92% below the market average36.92% below the market average36.92% below the market average36.92% below the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 28-Mar-2024

Time Volume / Share Price
14:39 6,000 @ 4,420.00p
16:27 453 @ 4,406.00p
16:27 455 @ 4,400.00p
16:25 25 @ 4,431.00p
16:24 22 @ 4,499.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page